WHO Admits Everyone Who Receives a MonkeyPox Vaccine is Part of a “Clinical Trial”

WHO Admits Everyone Who Receives a MonkeyPox Vaccine is Part of a “Clinical Trial” to Collect Data on its Effectiveness

An official from the World Health Organization (WHO) admitted on Saturday that everyone who received the Monkeypox vaccine is considered to be part of a “clinical study” for the purpose of data collecting so that researchers can learn more about the “effectiveness of the vaccine.”

On Saturday, WHO conducted a media briefing with WHO Director-General Tedros Adhanom Ghebreyesus and experts to discuss the Monkeypox outbreak.

Tim Nguyen, the Unit Head of Global Infectious Hazards Preparedness at the World Health Organization Emergency Programme, said that the vaccine efficacy is yet unknown since it has never been used on this scale before.

“I would like to underline one thing that is very important to WHO. We do have uncertainty around the effectiveness of these vaccines because they haven’t been used in this context and in this scale before,” Tim Nguyen stressed.

TRENDING: TRUMP WAS RIGHT: China Placed Huawei Equipment Atop Cell Towers on Purchased Farm Land Near US Military Bases - Capable of Disrupting and Capturing Signals